Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience
Colorectal Disease2013Vol. 15(7), pp. e365–72
Citations Over TimeTop 11% of 2013 papers
Abstract
CRS and HIPEC is a safe procedure when centralized as in Denmark. Favourable long-term outcome was achieved in selected patients with PC from colorectal cancer and pseudomyxoma peritonei. Short-term and long-term outcomes were comparable to results from international centres.
Related Papers
- → The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis(2021)11 cited
- → National disparity in guidelines for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis(2025)2 cited
- → Outcomes of Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis(2025)1 cited
- → Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal carcinomatosis: The impact of patients' selection policy on outcome and morbidity(2013)
- → Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin(2019)